Ampio Pharmaceuticals Launches Clinical Trial for COVID-19 Patients with Respiratory Distress - Colorado Bioscience Association

This topic is empty.

Viewing 1 post (of 1 total)

Author

Posts
11/02/2020 at 5:50 pm #11327

Colorado BioScience Association
Keymaster

The company is enrolling 40 patients in a Phase I trial to assess the safety and efficacy of inhaled Ampion™ for COVID-19 treatment.

More Information
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.